Cyclosporin A inhibits phorbol ester-induced activation of superoxide production in resident mouse peritoneal macrophages.

PubWeight™: 0.90‹?›

🔗 View Article (PMC 1133542)

Published in Biochem J on November 15, 1989

Authors

M D Chiara1, F Bedoya, F Sobrino

Author Affiliations

1: Departamento de Bioquímica Medica y Biología Molecular, Facultad de Medicina, Universidad de Sevilla, Spain.

Articles cited by this

Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91

Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem (1969) 43.83

The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature (1984) 28.58

Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest (1973) 17.56

Oxygen-dependent microbial killing by phagocytes (first of two parts). N Engl J Med (1978) 11.45

Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions (1976) 9.68

H2O2 release from human granulocytes during phagocytosis. I. Documentation, quantitation, and some regulating factors. J Clin Invest (1975) 5.90

Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem (1980) 5.86

Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes. Blood (1976) 3.34

Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science (1984) 3.17

Role of the superoxide anion in the myeloperoxidase-mediated antimicrobial system. J Biol Chem (1974) 2.61

Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A. J Exp Med (1984) 2.24

The inhibition by diphenyleneiodonium and its analogues of superoxide generation by macrophages. Biochem J (1987) 2.18

Studies on the mechanism of action of cyclosporin A. Immunobiology (1980) 2.05

Cyclosporin A inhibits lymphokine production but not the responses of macrophages to lymphokines. Immunology (1983) 1.99

Superoxide anion and hydrogen peroxide production by chemically elicited peritoneal macrophages--induction by multiple nonphagocytic stimuli. Cell Immunol (1981) 1.97

Internal pH changes associated with the activity of NADPH oxidase of human neutrophils. Further evidence for the presence of an H+ conducting channel. Biochem J (1988) 1.88

Superoxide generation by the electrogenic NADPH oxidase of human neutrophils is limited by the movement of a compensating charge. Biochem J (1988) 1.83

Superoxide production by digitonin-stimulated guinea pig granulocytes. The effects of N-ethyl maleimide, divalent cations; and glycolytic and mitochondrial inhibitors on the activation of the superoxide generating system. J Clin Invest (1978) 1.79

Mechanism of the superoxide-producing oxidase of neutrophils. O2 is necessary for the fast reduction of cytochrome b-245 by NADPH. Biochem J (1985) 1.73

Unsaturated fatty acids stimulate NADPH-dependent superoxide production by cell-free system derived from macrophages. Cell Immunol (1984) 1.73

Correlation between membrane potential changes and superoxide production in human granulocytes stimulated by phorbol myristate acetate. Evidence for defective activation in chronic granulomatous disease. J Biol Chem (1980) 1.71

Activation of NADPH-dependent superoxide production in a cell-free system by sodium dodecyl sulfate. J Biol Chem (1985) 1.63

Enzymatic basis of macrophage activation. Kinetic analysis of superoxide production in lysates of resident and activated mouse peritoneal macrophages and granulocytes. J Biol Chem (1984) 1.54

Gamma interferon synthesis by human thymocytes and T lymphocytes inhibited by cyclosporin A. Science (1983) 1.54

Activation of a NADPH oxidase from horse polymorphonuclear leukocytes in a cell-free system. J Leukoc Biol (1984) 1.41

Unsaturated fatty acids as second messengers of superoxide generation by macrophages. Cell Immunol (1983) 1.34

Cyclosporin A inhibits the proliferative response and the generation of helper, suppressor and cytotoxic T-cell functions in the autologous mixed lymphocyte reaction. Cell Immunol (1981) 1.22

Macrophage-lymphocyte interaction. III. Site of alloantiserum inhibition of T lymphocyte proliferation induced by allogeneic or aldehyde-bearing cells. J Immunol (1976) 1.17

Phosphorylation of the subunits of cytochrome b-245 upon triggering of the respiratory burst of human neutrophils and macrophages. Biochem J (1988) 1.12

Effects of in vivo treatments with cyclosporin-A on mouse cell-mediated immune responses. Int J Immunopharmacol (1981) 1.08

Production of superoxide by phagocytic leukocytes: a paradigm for stimulus-response phenomena. Curr Top Cell Regul (1986) 1.08

Measurement of O2- secreted by monocytes and macrophages. Methods Enzymol (1984) 1.04

Critical issues in cyclosporine monitoring: report of the Task Force on Cyclosporine Monitoring. Clin Chem (1987) 1.01

Cyclosporin receptor on mouse lymphocytes. Immunology (1980) 1.00

Effect of 3':5'-cyclic AMP on glucose transport in rat adipocytes. Proc Natl Acad Sci U S A (1976) 0.96

Separation of macrophages on plastic and glass surfaces. Methods Enzymol (1984) 0.92

Macrophage metabolism: activation of NADPH oxidation by phagocytosis. Biochem Biophys Res Commun (1971) 0.90

Dissociation of the 47-kilodalton protein phosphorylation from degranulation and superoxide production in neutrophils. J Leukoc Biol (1988) 0.88

Cyclosporine augments receptor-mediated cellular Ca2+ fluxes in isolated hepatocytes. J Biol Chem (1985) 0.88

Preventive and therapeutic effects of cyclosporin and valine2-dihydro-cyclosporin in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat. Immunology (1988) 0.87

Studies on the nature and activation of O2(-)-forming NADPH oxidase of leukocytes. Identification of a phosphorylated component of the active enzyme. Free Radic Res Commun (1985) 0.86

Concanavalin A induces Ca2+ mobilization, but only minimal inositol phospholipid breakdown in mouse B cells. J Immunol (1986) 0.84

The enzyme responsible for the respiratory burst in elicited guinea pig peritoneal macrophages. J Pathol (1982) 0.83

The weak immunosuppressant cyclosporine D as well as the immunologically inactive cyclosporine H are potent inhibitors in vivo of phorbol ester TPA-induced biological effects in mouse skin and of Ca2+/calmodulin dependent EF-2 phosphorylation in vitro. Biochem Biophys Res Commun (1988) 0.82

Control of fructose 2,6-bisphosphate levels in rat macrophages by glucose and phorbol ester. FEBS Lett (1989) 0.80

Signal transduction in human monocytes: relationship between superoxide production and the level of kinase C in the membrane. J Cell Physiol (1986) 0.79

Short-term stimulation by adenosine of basal and insulin-induced glycogen synthesis in rat adipose tissue. Biochim Biophys Acta (1986) 0.77

Articles by these authors

The quasispecies (extremely heterogeneous) nature of viral RNA genome populations: biological relevance--a review. Gene (1985) 3.42

Multiple genetic variants arise in the course of replication of foot-and-mouth disease virus in cell culture. Virology (1983) 3.04

Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol (1994) 2.41

Studies on the mechanism of the antifungal action of benzoate. Biochem J (1983) 1.97

Fitness alteration of foot-and-mouth disease virus mutants: measurement of adaptability of viral quasispecies. J Virol (1991) 1.89

Establishment of cell lines persistently infected with foot-and-mouth disease virus. Virology (1985) 1.84

Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. J Virol (1992) 1.72

Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proc Natl Acad Sci U S A (1989) 1.71

Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem (1999) 1.59

A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. J Gen Virol (1990) 1.57

Fixation of mutations in the viral genome during an outbreak of foot-and-mouth disease: heterogeneity and rate variations. Gene (1986) 1.53

Difference in glucose sensitivity of liver glycolysis and glycogen synthesis. Relationship between lactate production and fructose 2,6-bisphosphate concentration. Biochem J (1984) 1.49

Methylation-dependent gene silencing induced by interleukin 1beta via nitric oxide production. J Exp Med (1999) 1.45

A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol (1997) 1.36

A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol (2001) 1.29

Design of primers for PCR amplification of highly variable genomes. Comput Appl Biosci (1993) 1.16

Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene (1988) 1.12

VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol (1992) 1.10

Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J Virol (1991) 1.07

Gene encoding capsid protein VP1 of foot-and-mouth disease virus: a quasispecies model of molecular evolution. Proc Natl Acad Sci U S A (1988) 1.05

Recombinant viruses expressing the foot-and-mouth disease virus capsid precursor polypeptide (P1) induce cellular but not humoral antiviral immunity and partial protection in pigs. Virology (1999) 1.02

Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol (2001) 1.01

Infection with foot-and-mouth disease virus results in a rapid reduction of MHC class I surface expression. J Gen Virol (1998) 1.00

Genetic and phenotypic variability during replication of foot-and-mouth disease virus in swine. Virology (1990) 0.96

In vivo analysis of the stability and fitness of variants recovered from foot-and-mouth disease virus quasispecies. J Gen Virol (1998) 0.96

Immunogenicity of non-structural proteins of foot-and-mouth disease virus: differences between infected and vaccinated swine. Arch Virol (1994) 0.95

Primer design for specific diagnosis by PCR of highly variable RNA viruses: typing of foot-and-mouth disease virus. Virology (1992) 0.95

Comparison of vaccine strains and the virus causing the 1986 foot-and-mouth disease outbreak in Spain: epizootiological analysis. Virus Res (1990) 0.95

Identification of T-cell epitopes in nonstructural proteins of foot-and-mouth disease virus. J Virol (2001) 0.95

Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. J Gen Virol (1992) 0.94

Association of bovine DRB3 alleles with immune response to FMDV peptides and protection against viral challenge. Vaccine (2000) 0.91

Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Virus Res (1989) 0.90

A method for determining the position and size of optimal sequence regions for phylogenetic analysis. J Mol Evol (1995) 0.89

A RT-PCR assay for the differential diagnosis of vesicular viral diseases of swine. J Virol Methods (1998) 0.89

p53 transactivation of the HIV-1 long terminal repeat is blocked by PD 144795, a calcineurin-inhibitor with anti-HIV properties. J Biol Chem (1998) 0.89

Interspecies major histocompatibility complex-restricted Th cell epitope on foot-and-mouth disease virus capsid protein VP4. J Virol (2000) 0.88

NO induces a cGMP-independent release of cytochrome c from mitochondria which precedes caspase 3 activation in insulin producing RINm5F cells. FEBS Lett (1999) 0.88

Hormonal regulation of fructose 2,6-bisphosphate levels in epididymal adipose tissue of rat. FEBS Lett (1985) 0.87

Evidence of partial protection against foot-and-mouth disease in cattle immunized with a recombinant adenovirus vector expressing the precursor polypeptide (P1) of foot-and-mouth disease virus capsid proteins. J Gen Virol (1999) 0.87

A porcine CD8+ T cell clone with heterotypic specificity for foot-and-mouth disease virus. J Gen Virol (1996) 0.86

Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Virology (1994) 0.86

Fixation of mutations at the VP1 gene of foot-and-mouth disease virus. Can quasispecies define a transient molecular clock? Gene (1991) 0.86

Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: the effect of immunotherapy. J Allergy Clin Immunol (2001) 0.85

Specific inhibition of aphthovirus infection by RNAs transcribed from both the 5' and the 3' noncoding regions. J Virol (1994) 0.85

Transient inhibition of foot-and-mouth disease virus infection of BHK-21 cells by antisense oligonucleotides directed against the second functional initiator AUG. Antiviral Res (1993) 0.85

A computer program for the design of PCR primers for diagnosis of highly variable genomes. J Virol Methods (1993) 0.84

Estimates by computer simulation of genetic distances from comparisons of RNAse A mismatch cleavage patterns. J Virol Methods (1993) 0.83

Evidence for involvement of c-Src in the anti-apoptotic action of nitric oxide in serum-deprived RINm5F cells. Cell Signal (2001) 0.83

Molecular epidemiology of foot-and-mouth disease virus type O. J Gen Virol (1993) 0.83

Modulation of the inhibition of respiratory burst in mouse macrophages by cyclosporin A: effect of in vivo treatment, glucocorticoids and the state of activation of cells. Immunology (1991) 0.83

Stimulation of glycolysis as an activation signal in rat peritoneal macrophages. Effect of glucocorticoids on this process. Biochem J (1992) 0.82

Sodium nitroprusside-induced mitochondrial apoptotic events in insulin-secreting RINm5F cells are associated with MAP kinases activation. Exp Cell Res (2001) 0.82

Heterotypic inhibition of foot-and-mouth disease virus infection by combinations of RNA transcripts corresponding to the 5' and 3' regions. Antiviral Res (1999) 0.82

Characterization of calcineurin in human neutrophils. Inhibitory effect of hydrogen peroxide on its enzyme activity and on NF-kappaB DNA binding. J Biol Chem (1999) 0.82

Glucocorticoids inhibit fructose 2,6-bisphosphate synthesis in rat thymocytes. Opposite effect of cycloheximide. Biochim Biophys Acta (1991) 0.82

Modulation of phorbol ester-induced respiratory burst by vanadate, genistein, and phenylarsine oxide in mouse macrophages. Free Radic Biol Med (1995) 0.82

Stable expression of antisense RNAs targeted to the 5' non-coding region confers heterotypic inhibition to foot-and-mouth disease virus infection. J Gen Virol (2003) 0.82

IgE-dependent release of myeloperoxidase by neutrophils from allergic patients. Clin Exp Allergy (2001) 0.81

The effect of experimental hypothyroidism on phosphofructokinase activity and fructose 2,6-bisphosphate concentrations in rat heart. Biochem J (1987) 0.81

The inactivation of phosphorylase and activation of glycogen synthase in the adipose tissue. Eur J Biochem (1980) 0.81

Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peritoneal neutrophils. Clin Exp Immunol (2001) 0.81

Direct PCR detection of foot-and-mouth disease virus. J Virol Methods (1994) 0.80

Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages. Evidence of a direct effect on nitric oxide synthase activity. Immunology (1995) 0.80

An RT-PCR assay for the specific detection of classical swine fever virus in clinical samples. Vet Res (1998) 0.80

Control of fructose 2,6-bisphosphate levels in rat macrophages by glucose and phorbol ester. FEBS Lett (1989) 0.80

Effect of prolonged fasting upon insulin and glucagon secretion from isolated rat pancreatic islets. Rev Esp Fisiol (1978) 0.79

Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain. Vaccine (1992) 0.79

A procedure for detecting selection in highly variable viral genomes: evidence of positive selection in antigenic regions of capsid protein VP1 of foot-and-mouth disease virus. J Virol Methods (1998) 0.79

Thimerosal induces calcium mobilization, fructose 2,6-bisphosphate synthesis and cytoplasmic alkalinization in rat thymus lymphocytes. Biochim Biophys Acta (1991) 0.79

Decrease in free-radical production with age in rat peritoneal macrophages. Biochem J (1995) 0.79

Nicotinamide inhibits inducible nitric oxide synthase enzyme activity in macrophages by allowing nitric oxide to inhibit its own formation. Life Sci (1997) 0.79

Enhancement of Antigen-specific functional responses by neutrophils from allergic patients. J Exp Med (1996) 0.78

Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages. Cell Immunol (1996) 0.78

Gene expression profiles in the cerebellum of transgenic mice over expressing the human FMR1 gene with CGG repeats in the normal range. Genet Mol Res (2012) 0.78

Activation of peritoneal macrophages during the prediabetic phase in low-dose streptozotocin-treated mice. FEBS Lett (1993) 0.78

Myeloperoxidase release after allergen-specific conjunctival challenge. J Asthma (2004) 0.78

Analysis of the B and T cell response in guinea pigs induced with recombinant vaccinia expressing foot-and-mouth disease virus structural proteins. Arch Virol (1998) 0.77

Protection from nicotinamide inhibition of interleukin-1 beta-induced RIN cell nitric oxide formation is associated with induction of MnSOD enzyme activity. Endocrinology (1996) 0.77

ACTH stimulates fructose 2,6-bisphosphate synthesis and glycolysis in Y-1 adrenal tumor cells. Biochem Int (1988) 0.77

Biochemical design features of the pancreatic islet cell glucose-sensory system. Adv Exp Med Biol (1986) 0.77

Molecular epidemiology of classical swine fever in Cuba. Virus Res (1999) 0.77

Respiratory burst in neutrophils from asthmatic patients. J Asthma (2002) 0.77

Effect of thimerosal and other sulfhydryl reagents on calcium permeability in thymus lymphocytes. Biochem Pharmacol (1995) 0.77

Response to retreatment with interferon-alpha plus ribavirin in chronic hepatitis C patients is independent of the NS5A gene nucleotide sequence. Am J Gastroenterol (1999) 0.77

Short-term stimulation by adenosine of basal and insulin-induced glycogen synthesis in rat adipose tissue. Biochim Biophys Acta (1986) 0.77

IgE-mediated downregulation of L-selectin (CD62L) on lymphocytes from asthmatic patients. Allergy (2001) 0.77

Inhibitory effect of interferon-alpha on respiratory burst and glucose metabolism in phagocytic cells. J Interferon Res (1994) 0.77

In vitro glucose reversal of the inhibitory effect of fasting on epinephrine-induced lipolysis. Biochem Biophys Res Commun (1981) 0.77

Regulation of fructose-2,6-bisphosphate and glycogen synthesis by dichloroacetate and phenazine methosulphate in rat adipose tissue. Biochem Int (1986) 0.76

Involvement of cyclic AMP-dependent protein kinase on the phosphorylase kinase inhibition by glucose-6-phosphate in adipose tissue extracts. Horm Metab Res (1986) 0.76

Allergen-dependent CD14 modulation and apoptosis in monocytes from allergic patients. Allergy (2003) 0.76

Identification of optimal regions for phylogenetic studies on VP1 gene of foot-and-mouth disease virus: analysis of types A and O Argentinean viruses. Vet Res (2001) 0.76

In vitro synthesis of foot-and-mouth disease virus specific antibodies by porcine leukocytes. Arch Virol (1995) 0.76

A newly synthesized molecule derived from ruthenium cation, with antitumour activity, activates NADPH oxidase in human neutrophils. Biochem J (1997) 0.75

Stimulating role of potassium ions and ouabain on glycogen synthesis in adipose tissue. Biochem J (1982) 0.75

Cyclosporin A antagonizes phenylephrine, oxytocin and angiotensin effects on glucose metabolism in rat thymus lymphocytes. Biochim Biophys Acta (1994) 0.75

Beta-naphthylamine induces anion superoxide production in rat peritoneal macrophages. Biochem Pharmacol (1992) 0.75

Streptozotocin-induced diabetes increases fructose 2,6-biphosphate levels and glucose metabolism in thymus lymphocytes. Life Sci (1996) 0.75

Streptozotocin-induced diabetes increases fructose 2,6-bisphosphate levels and glucose metabolism in rat macrophages. Biochem Med Metab Biol (1993) 0.75